Shane Foo

7PUBLICATIONS

49CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 05, 2026

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity.

|Oct 22, 2025

Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancer.

Charleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev

|Jul 15, 2025

Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Victoria Roulstone, Joan Kyula-Currie, James Wright

|Jul 08, 2025

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

|May 24, 2025

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Victoria Roulstone, Joan Kyula-Currie, James Wright

|Feb 26, 2025

PBRM1 directs PBAF to pericentromeres and protects centromere integrity.

Karen A Lane, Alison Harrod, Lillian Wu

Pageof 2

Frequent Collaborators

Alan Melcher

Kevin J Harrington

Emmanuel C Patin

Charleen Chan Wah Hak

Jyoti S Choudhary

Antonio Rullan

Elizabeth S Appleton

Victoria Roulstone

Pablo Nenclares

Masahiro Ono

Frequent Collaborators

Alan Melcher

Kevin J Harrington

Emmanuel C Patin

Charleen Chan Wah Hak